Orthofix's trial is evaluating patients treated for cervical degenerative disc disease at two contiguous vertebral levels with the M6-C disc compared to ACDF.
The product is an anterior cervical interbody fusion system for use in adult patients with cervical disc degeneration and/or cervical spinal instability.
Patent relates to a method for assembling a cervical disc replacement in which a mobile core is retained using the firm’s proprietary core retention technology.